If RVX were to indeed do what Paul Moon said (only announce if the trial successfully met end points...and nothing else), then the share price will most likely not go up that much initially.
The option price is indicating $5.6, so I am guessing we land up somewhere between $6 and $8. That will allow the risk averse investors one more chance to jump in and buy shares. Volumes going up as the share price goes up...will set up a virtuous cycle.
It will also allow RVX share price to go up in a slope, rather than an elevator...over the next several months.
Meanwhile, this higher share price will allow the warrant holders, particularly Shenzhen Hepalink and Eastern Capital, to subscribe to the new shares...and most likely sell some into the market.
